Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
The Business Behind The New York Times Bestseller Lists Influence Gamesmanship and Market Power Wall Street Gains Momentum Following Reported ChinaUS Oil Deal Berkshire Filing Suggests Warren Buffetts Tiny Purchase in March May Have Been Revealed IndiaUAE Energy Partnership Provides Partial Buffer Amid Persistent Global Uncertainties Traws Pharma TRAW Stock Today Rallies 087 Resistance at 183 20260514 Terrestrial Energy Quarterly Update Highlights Reactor Project Progress and DOE Commercialization Support SkyWater Technology SKYT Stock Analysis RangeBound Near 3425 20260519 Silicon SIMO Q1 2026 Beat Revenue NA EPS Exceeds by Significant The Mandalorian and Grogu Achieves Record Rotten Tomatoes Audience Score Amid CriticAudience Divide Home Equity Loan and HELOC Rates Stay Low as of May 27 2026 But Comparison Shopping Remains Key Japans Nikkei 225 Surpasses 64000 for First Time as Oil Prices Slide on Hormuz Reopening Hopes US Stock Futures Edge Higher as Optimism Builds on USIran Talks and AI Rebound SP 500 Eyes Eighth Consecutive Weekly Gain Latin American Leaders Call for Innovative Housing Finance and ClimateResilient Urban Development at WUF13 SK Hynix and Micron Join 1 Trillion Club Amid Surging AI Chip Demand GWW Q1 2026 Earnings EPS Exceeds Estimates by Nearly 13 Despite Slight Stock Decline Five9 Q1 2026 Earnings EPS Surpasses Estimates by 913 as Stock Gains 421 HR Earnings Overview 20260522 IMPP Q1 2026 Earnings EPS Surges 67 Above Estimates Driving DoubleDigit Stock Rally Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment NUVB Q1 2026 Earnings Narrow EPS Beat Reflects Continued Pipeline Progress Imunon Inc IMNN Holds Steady Near Support Following Modest Decline Day One Biopharmaceuticals DAWN Holds Steady at 2153 Consolidating Between Key Levels Destination XL Group DXLG Edges Higher Amid Tight Trading Range Seres Therapeutics MCRB Declines 593 as Selling Pressure Intensifies Teck Resources TECK Holds Steady Near 63 as Consolidation Continues